Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ionis Pharmaceuticals 2855 GAZELLE COURT CARLSBAD CA 92010 USA

P: 760-931-9200 F: 760-268-4922

Description:

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

Key Statistics

Overview:

Market Capitalization, $K 5,196,897
Shares Outstanding, K 141,798
Annual Sales, $ 810,460 K
Annual Net Income, $ -28,600 K
Last Quarter Sales, $ 141,920 K
Last Quarter Net Income, $ -65,170 K
60-Month Beta 0.78
% of Insider Shareholders 2.40%
% of Institutional Shareholders 95.16%
Float, K 138,395
% Float 97.60%
Short Volume Ratio 0.16

Growth:

1-Year Return 2.12%
3-Year Return -44.13%
5-Year Return -25.75%
5-Year Revenue Growth 133.82%
5-Year Earnings Growth 72.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.46 on 05/04/22
Next Earnings Date N/A
Earnings Per Share ttm -0.20
EPS Growth vs. Prev Qtr -132.62%
EPS Growth vs. Prev Year 28.12%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IONS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -0.46%
Return-on-Assets % -0.12%
Profit Margin % -3.53
Net Margin % N/A
Debt/Equity 1.62
Price/Sales 6.45
Price/Cash Flow 391.53
Price/Book 7.37
Book Value/Share 5.00
Interest Coverage -2.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar